News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|May 1, 2000

Cycles--in business and otherwise

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Michael Reed, MD, MSCP, on proposing sexual health as a pillar of women's health

Michael Reed, MD, MSCP, on proposing sexual health as a pillar of women's health

ByMichael A. Reed, MD, MSCP

July 28th 2026

Mark Simon, MD, MMM, on the hospitalist care model

Mark Simon, MD, MMM, on the OB hospitalist care model

ByMark Simon, MD, MMM

June 10th 2026

Parental support package mitigates burnout in childbearing physicians in training

Parental support package mitigates burnout in childbearing physicians in training

ByJoshua Fitch, Senior Editor

May 14th 2026

AMA, ACOG announce restructuring of maternity care coding for 2027 | Image credit: Stock.adobe.com

AMA, ACOG announce restructuring of maternity care coding for 2027

ByJoshua Fitch, Senior Editor

April 23rd 2026

Physicians say women's health is progressing, but earlier diagnosis is still key | Image Credit: © Flamingo Images - © Flamingo Images - stock.adobe.com.

Physicians say women's health is progressing, but earlier diagnosis is still key

ByJoshua Fitch, Senior Editor

March 20th 2026

Latest CME

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Endometriosis as a systemic disease, with Hugh Taylor, MD

FDA accepts extended duration sNDA for MIUDELLA IUD

Certolizumab pegol's FDA breakthrough designation, atogepant's LUNA results, deep implant removal guidance

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo